Quidel Corporation (QDEL): Price and Financial Metrics

QDEL POWR Grades

• QDEL scores best on the Value dimension, with a Value rank ahead of 87.78% of US stocks.
• QDEL's strongest trending metric is Growth; it's been moving down over the last 177 days.
• QDEL's current lowest rank is in the Momentum metric (where it is better than 1.11% of US stocks).

QDEL Stock Summary

• QDEL's went public 30.94 years ago, making it older than 83.37% of listed US stocks we're tracking.
• With a year-over-year growth in debt of 1,896.85%, QUIDELORTHO CORP's debt growth rate surpasses 98.7% of about US stocks.
• Revenue growth over the past 12 months for QUIDELORTHO CORP comes in at 62.29%, a number that bests 86.1% of the US stocks we're tracking.
• If you're looking for stocks that are quantitatively similar to QUIDELORTHO CORP, a group of peers worth examining would be SANW, LFUS, JMIA, ISPC, and CEMI.
• Visit QDEL's SEC page to see the company's official filings. To visit the company's web site, go to www.quidel.com.

QDEL Valuation Summary

• In comparison to the median Healthcare stock, QDEL's price/earnings ratio is 68.78% lower, now standing at 6.9.
• Over the past 243 months, QDEL's price/earnings ratio has gone down 37.1.

Below are key valuation metrics over time for QDEL.

QDEL Growth Metrics

The year over year cash and equivalents growth rate now stands at 30.02%.
• Its year over year net cashflow from operations growth rate is now at -37.49%.
• The 2 year net cashflow from operations growth rate now stands at 343.2%.

Over the past 49 months, QDEL's revenue has gone up $2,531,739,000.

The table below shows QDEL's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	3,036.326	1,037.277	809.753
2022-06-30	2,762.262	1,124.036	1,006.305
2022-03-31	2,325.472	721.384	1,006.078
2021-12-31	1,698.551	805.869	704.226
2021-09-30	1,870.887	923.623	883.039
2021-06-30	1,837.209	917.019	899.555

QDEL's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• QDEL has a Quality Grade of B, ranking ahead of 85.03% of graded US stocks.
• QDEL's asset turnover comes in at 1.046 -- ranking 21st of 680 Pharmaceutical Products stocks.
• SYRS, ONVO, and SESN are the stocks whose asset turnover ratios are most correlated with QDEL.

The table below shows QDEL's key quality metrics over time.